Back
Q2 Holdings Vs. Akero Therapeutics Industry Stock Comparison
Buy
55
QTWO
Q2 Holdings
Last Price:
$95.11
Seasonality Move:
2.88%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Buy
55
Q2 Holdings (QTWO)
is a Buy
Is Q2 Holdings a Buy, Sell or Hold?
-
The current Q2 Holdings [QTWO] share price is $97.70. The Score for QTWO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
QTWO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.36. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QTWO Stock Price Chart
What is Q2 Holdings's stock price today?
-
The Q2 Holdings share price today is $97.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QTWO is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
QTWO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.33 | Sell |
Relative Strength Index (14 RSI): | 51.08 | Buy |
Chaikin Money Flow: | -268616 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.95 - 101.97) | Buy |
Bollinger Bands (100): | (80.1 - 103.56) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.46 | Buy |
Relative Strength Index (14 RSI): | 86.44 | Buy |
Chaikin Money Flow: | -1207308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.44 - 40.6) | Buy |
Bollinger Bands (100): | (24.53 - 35.29) | Buy |
QTWO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.42 | Buy |
20-day SMA: | 95.92 | Buy |
50-day SMA: | 101.23 | Sell |
200-day SMA: | 77.41 | Buy |
8-day EMA: | 95.84 | Buy |
20-day EMA: | 96.62 | Buy |
50-day EMA: | 96.98 | Buy |
200-day EMA: | 80.06 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.44 | Buy |
20-day SMA: | 31.04 | Buy |
50-day SMA: | 30.48 | Buy |
200-day SMA: | 26.55 | Buy |
8-day EMA: | 43.24 | Buy |
20-day EMA: | 35.07 | Buy |
50-day EMA: | 31.47 | Buy |
200-day EMA: | 28.51 | Buy |
Q2 Holdings Earnings Growth & QTWO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.51 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $0.02 per share.
Q2 Holdings Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |